A detailed history of Kilter Group LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Kilter Group LLC holds 82 shares of DVAX stock, worth $825. This represents 0.0% of its overall portfolio holdings.

Number of Shares
82
Holding current value
$825
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$9.4 - $12.87 $770 - $1,055
82 New
82 $814,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.27B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Kilter Group LLC Portfolio

Follow Kilter Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kilter Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kilter Group LLC with notifications on news.